PJA-15922-70229
4 vaccinations
4 coded responses
12 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 940 / CA
- Registered
- 2021-04-08
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Registered dependents
JD9-23771-51142
Child or adolescent in my care · Male · 2022-01-12
WNX-11204-78689
Child or adolescent in my care · Male · 2022-01-12
Timeline
-
2021-04-08
Registered in v-safe
-
2021-04-08
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-08
-
2021-04-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-10
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-14
-
2021-04-16
Survey response — day 7, dose 1MedDRA: Cough — Feeling: Good · ChillsFree text: Mild morning coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-01
Survey response — day 21, single doseMedDRA: Oropharyngeal pain — Feeling: FairFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-20
Survey response — day 42, single doseMedDRA: Arthralgia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Joint painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-07
Dose 2 — Pfizer-BioNTech
- 2021-07-12
-
2021-07-28
Dose 3 — Pfizer-BioNTech
-
2022-01-11
Dose 4 — Moderna
-
2022-01-13
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-01-16
- 2022-01-22
-
2022-07-14
Survey response — 6 months, dose 4MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Has COVID between 6/20/2022 to 07/08/2022MedDRA releases: 2024-11 · check-in free text available
-
2022-07-14
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-07-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-08 | Janssen/Johnson & Johnson | |
| 2 | 2021-07-07 | Pfizer-BioNTech | No |
| 3 | 2021-07-28 | Pfizer-BioNTech | No |
| 4 | 2022-01-11 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 7 — day 7, dose 1
Systemic reaction (other): Mild morning cough
Release 8 — day 21, single dose
Symptoms: Sore throat
Release 8 — day 42, single dose
Symptoms: Joint pain
Release 12 — 6 months, dose 4
Symptoms: Has COVID between 6/20/2022 to 07/08/2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release